At a glance
ClinicalIndex Comparison RecordN/ACompleted· 160 enrolled
Drug / intervention
Doxycycline Tabletsdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of Doxycycline as a Combination Therapy in the Treatment of Rheumatoid Arthritis
In Brief
A clinical study evaluating Doxycycline Tablets for Rheumatoid Arthritis. Completed, enrolled 160 participants across 1 site.
Detailed Summary
Rheumatoid Arthritis (RA) is a chronic inflammatory disease characterized by joint swelling, joint tenderness and destruction of synovial joints, leading to severe disability and premature mortality.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRheumatoid Arthritis
CountriesEgypt
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedJun 2017
Enrollment StartOct 2019
Primary CompletionFeb 2020
TodayJul 2026
First PostedJun 21, 2017
Enrollment StartOct 1, 2019
Primary CompletionFeb 20, 2020
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 9.0 years ago
Interventions
Doxycycline Tabletsdrug
MMP-3 and MMP-9 will be done with blood samples using ELISA technique CIMT will be done using colored doppler ultrasound